These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8761842)
1. Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension. Böhlen L; Bienz R; Doser M; Papiri M; Shaw S; Riesen W; Weidmann P J Cardiovasc Pharmacol; 1996 Jun; 27(6):770-6. PubMed ID: 8761842 [TBL] [Abstract][Full Text] [Related]
2. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients. Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016 [TBL] [Abstract][Full Text] [Related]
3. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930 [TBL] [Abstract][Full Text] [Related]
4. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients. Bak JF; Gerdes LU; Sørensen NS; Pedersen O Am J Med; 1992 Apr; 92(4B):69S-72S. PubMed ID: 1580283 [TBL] [Abstract][Full Text] [Related]
5. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia. Middeke M; Krone W J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014 [TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus. Derosa G; Cicero AF; Ciccarelli L; Fogari R Clin Ther; 2003 Jul; 25(7):2006-21. PubMed ID: 12946547 [TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril. New JP; Bilous RW; Walker M Diabet Med; 2000 Feb; 17(2):134-40. PubMed ID: 10746484 [TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents. Lerch M; Teuscher AU; Beissner P; Schneider M; Shaw SG; Weidmann P J Cardiovasc Pharmacol; 1998 Apr; 31(4):576-80. PubMed ID: 9554807 [TBL] [Abstract][Full Text] [Related]
10. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension. Huang SS; Wu TC; Lin SJ; Chen JW Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415 [TBL] [Abstract][Full Text] [Related]
11. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure. Fliser D; Rett K; Hübinger A; Ritz E Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576 [TBL] [Abstract][Full Text] [Related]
12. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension. Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women. Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159 [TBL] [Abstract][Full Text] [Related]
14. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group. Overlack A; Adamczak M; Bachmann W; Bönner G; Bretzel RG; Derichs R; Krone W; Lederle RM; Reimann HJ; Zschiedrich H Am J Med; 1994 Aug; 97(2):126-34. PubMed ID: 8059778 [TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril. Allemann Y; Baumann S; Jost M; Ferrari P; Shaw S; Riesen W; Weidmann P Eur J Clin Pharmacol; 1992; 42(3):275-80. PubMed ID: 1533588 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
17. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril. Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353 [TBL] [Abstract][Full Text] [Related]
18. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance. Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313 [TBL] [Abstract][Full Text] [Related]
19. Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension. de Courten M; Ferrari P; Schneider M; Böhlen L; Shaw S; Riesen W; Heynen G; Weidmann P Eur J Clin Pharmacol; 1993; 44(5):457-62. PubMed ID: 8359183 [TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]